OBJECTIVES: To determine 18-month neurodevelopmental outcome of survivors of complex open heart surgery at </=6 weeks of age through an interprovincial program and to explore preoperative, operative, and postoperative outcome predictors. Study design Of 85 children from this inception cohort (21% mortality), 67 18-month-old survivors received multidisciplinary assessment including the Bayley Scales of Infant Development-II. Cumulative risk for adverse outcome was determined through univariate and multivariate analyses. RESULTS: Survival of the 85 children included 23 of 23 after arterial switch, 16 of 26 after Norwood, six of six after total anomalous pulmonary venous drainage repair, and 22 of 30 after miscellaneous repair. Outcomes were as follows: in-hospital death, 14 (16%); postdischarge death, four (5%); motor/sensory disability, three (4%); motor/mental delay (<70), 21 (25%); and intact survivors, 43 (50%). Cohort mental (84+/-17) and motor (80+/-22) scores were lower for those with chromosomal abnormalities, 67+/-16 and 61+/-17, respectively. Fifty-five percent of the outcome variance was explained by duration of preoperative ventilation, 18%; genetic anomaly, 5%; intraoperative variables, 18%; and postoperative variables, 14%. CONCLUSIONS: Risk for adverse outcome is cumulative, with preoperative determinants contributing significantly to total variance. Potentially modifiable variables should be sought in an attempt to improve outcome.
OBJECTIVES: To determine 18-month neurodevelopmental outcome of survivors of complex open heart surgery at </=6 weeks of age through an interprovincial program and to explore preoperative, operative, and postoperative outcome predictors. Study design Of 85 children from this inception cohort (21% mortality), 67 18-month-old survivors received multidisciplinary assessment including the Bayley Scales of Infant Development-II. Cumulative risk for adverse outcome was determined through univariate and multivariate analyses. RESULTS: Survival of the 85 children included 23 of 23 after arterial switch, 16 of 26 after Norwood, six of six after total anomalous pulmonary venous drainage repair, and 22 of 30 after miscellaneous repair. Outcomes were as follows: in-hospital death, 14 (16%); postdischarge death, four (5%); motor/sensory disability, three (4%); motor/mental delay (<70), 21 (25%); and intact survivors, 43 (50%). Cohort mental (84+/-17) and motor (80+/-22) scores were lower for those with chromosomal abnormalities, 67+/-16 and 61+/-17, respectively. Fifty-five percent of the outcome variance was explained by duration of preoperative ventilation, 18%; genetic anomaly, 5%; intraoperative variables, 18%; and postoperative variables, 14%. CONCLUSIONS: Risk for adverse outcome is cumulative, with preoperative determinants contributing significantly to total variance. Potentially modifiable variables should be sought in an attempt to improve outcome.
Authors: Billie-Jean Martin; I De Villiers Jonker; Ari R Joffe; Gwen Y Bond; Bryan V Acton; David B Ross; Charlene M T Robertson; Ivan M Rebeyka; Joseph Atallah Journal: Pediatr Cardiol Date: 2017-03-24 Impact factor: 1.655
Authors: Billie-Jean Martin; David B Ross; Mohammed Al Aklabi; Joyce Harder; John D Dyck; Ivan M Rebeyka Journal: Pediatr Cardiol Date: 2017-08-22 Impact factor: 1.655
Authors: Charlene M T Robertson; Reg S Sauve; Ari R Joffe; Gwen Y Alton; Diane M Moddemann; Patricia M Blakley; Anne R Synnes; Irina A Dinu; Joyce R Harder; Reeni Soni; Jaya P Bodani; Ashok P Kakadekar; John D Dyck; Derek G Human; David B Ross; Ivan M Rebeyka Journal: Cardiol Res Pract Date: 2011-05-08 Impact factor: 1.866
Authors: Po-Yin Cheung; Morteza Hajihosseini; Irina A Dinu; Heather Switzer; Ari R Joffe; Gwen Y Bond; Charlene M T Robertson Journal: Front Pediatr Date: 2021-01-28 Impact factor: 3.418
Authors: Joseph Atallah; Gonzalo Garcia Guerra; Ari R Joffe; Gwen Y Bond; Sunjidatul Islam; M Florencia Ricci; Mohammed AlAklabi; Ivan M Rebeyka; Charlene M T Robertson Journal: J Am Heart Assoc Date: 2020-02-11 Impact factor: 5.501
Authors: Darlene Huisenga; Sacha La Bastide-Van Gemert; Andrew Van Bergen; Jane Sweeney; Mijna Hadders-Algra Journal: Dev Med Child Neurol Date: 2020-03-09 Impact factor: 5.449